The Bloodline with Blood Cancer United Podcast Podcast By Blood Cancer United cover art

The Bloodline with Blood Cancer United Podcast

The Bloodline with Blood Cancer United Podcast

By: Blood Cancer United
Listen for free

A podcast for patients and caregiversThe Bloodline with LLS - Blood Cancer United Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow

    Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow
    Mar 31 2026
    Marlise Luskin, MD With so many new advances in acute lymphoblastic leukemia (ALL), understanding today’s treatment landscape can give patients a clearer, more hopeful outlook. In this episode, we speak with Marlise Luskin, MD of the Dana-Farber Cancer Institute, about what adults should know when facing a diagnosis of acute lymphoblastic leukemia. Dr. Luskin helps listeners understand how ALL develops, how subtypes are identified, and why genetics play an important role in guiding treatment. She discusses current therapies including chemotherapy, targeted agents and immunotherapies including CAR T-cell therapy, as well as how care teams monitor progress and manage side effects. While ALL is a complex disease, patients and caregivers will hear clear explanations, practical information, and meaningful reasons to feel hopeful about the advances shaping ALL care today. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Acute lymphoblastic leukemia (ALL)Minimal/measurable residual disease (MRD) fact sheetAllogeneic stem cell transplantationClinical Trial Support CenterALL Children and Teens booklet Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Support groups Caregiver support Caregiver WorkbookYoung Adult ResourcesSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by Syndax Pharmaceuticals Inc. The post Acute Lymphoblastic Leukemia (ALL): The New Tools Shaping Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    42 mins
  • Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence

    Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence
    Mar 12 2026
    Andrew Yee, MD Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story. In this episode, Dr. Andrew Yee of Massachusetts General Hospital explains what myeloma is, how it’s diagnosed, and why new treatment options, from four-drug regimens to CAR T-cell therapy and bispecific antibodies, are transforming patient outcomes. With enthusiasm and relatable analogies, he highlights how patients may progress from periods of significant challenges to reaching a level of stability and well‑being that allows them to live fully. This conversation offers clarity, confidence, and real optimism for anyone navigating myeloma. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: Multiple myelomaAmyloidosisAutologous stem cell transplantationCAR T-cell therapyImmunotherapy fact sheetClinical Trial Support Center Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by AbbVie Inc.; Bristol Myers Squibb; Genentech, A Member of the Roche Group; GSK plc.; Johnson & Johnson. The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    51 mins
  • Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives

    Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives
    Feb 26 2026
    CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapyClinical Trial Support CenterCAR T-Cell Therapy: A Path of Hope and Healing Video SeriesBloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell TherapyHematology Horizons vlog: CAR T-Cell Therapy and the Patient ExperienceCAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; Novartis Pharmaceuticals Corporation. The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first appeared on The Bloodline with Blood Cancer United Podcast.
    Show more Show less
    49 mins
No reviews yet